The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

2 Jun 2009 12:14

RNS Number : 2042T
Banc of America Securities Ltd
02 June 2009
 



DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Banc of America Securities Limited

Company dealt in

OJSC Polyus Gold

Class of relevant security to which the dealings being disclosed relate (Note 1)

ADR

Date of dealing

01 June 2009

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

5,578

25.87 USD

25.87 USD

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

0

0

0

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 3)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Date of disclosure

02 June 2009

Contact name

EMEA Control Room

Telephone number

020 7174 5500

Name of offeree/offeror with which connected

KazakhGold Group Limited

Nature of connection (Note 6)

Merrill Lynch International, an affiliate of Banc of America Securities Limited, is acting as connected advisor.

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMILFLLRFIFIIA
Date   Source Headline
11th May 202312:00 pmRNSFY2022 dividend recommendation
28th Apr 20234:15 pmRNSAnnual Review
28th Apr 202312:02 pmRNSNotice of 2022 AGM
20th Mar 202311:15 amRNSNotice of change of the DR programs depositary
17th Mar 20233:01 pmRNSUpdate on payments on 2023 and 2024 Eurobonds
17th Mar 20233:00 pmRNSUpdate on payments on 2023 and 2024 Eurobonds
15th Mar 20232:01 pmRNSFinancial results for 2H2022 and FY2022
14th Mar 20232:23 pmRNSNotice of financial results for 2H2022 and FY2022
21st Feb 20237:00 amRNSOperating results for 2H 2022 and full year 2022
16th Feb 20231:37 pmRNSPolyus priced 20 billion rouble bonds issue
14th Feb 20231:02 pmRNSRepayment of Eurobonds due 2023
14th Feb 20231:00 pmRNSRepayment of Eurobonds due 2023
3rd Feb 20233:32 pmRNSUpdate on Level I DR program
2nd Feb 20233:15 pmRNSUpdate on Depositary for DR programs
30th Nov 20223:33 pmRNSUpdate on coupon payments in respect of 2028 Notes
30th Nov 20223:30 pmRNSUpdate on coupon payments in respect of 2028 Notes
28th Nov 20223:30 pmRNSChanges in top management
30th Sep 20223:51 pmRNSAGM results
22nd Sep 20224:58 pmRNSUpdate on coupon payments in respect of 2023 Notes
22nd Sep 20224:43 pmRNSUpdate on coupon payments in respect of 2023 Notes
21st Sep 20227:05 amRNSOperating results for the first half of 2022
21st Sep 20227:00 amRNSFinancial results for the first half of 2022
13th Sep 20224:47 pmRNSUpdate on coupon payments in respect of 2024 Notes
13th Sep 20224:45 pmRNSUpdate on coupon payments in respect of 2024 Notes
9th Sep 20229:03 amRNSConsent Solicitation Results
9th Sep 20229:00 amRNSConsent Solicitation Results
6th Sep 202210:01 amRNSNotice of 2H2021 Dividend Recommendation and AGM
30th Aug 20227:00 amRNSNotice of the first half of 2022 financial results
25th Aug 20224:05 pmRNSNoteholders’ consent solicitation extension
25th Aug 20224:00 pmRNSExtension of Consent Solicitation
24th Aug 202210:45 amRNSPJSC Polyus priced CNY 4.6 billion bonds issue
17th Aug 20221:12 pmRNSNotice to holders of depositary receipts
15th Aug 202212:54 pmRNSPJSC Polyus publishes its Climate Strategy
11th Aug 20223:03 pmRNSExtension of Consent Solicitation
11th Aug 20223:00 pmRNSExtension of Consent Solicitation
5th Aug 20221:35 pmRNSUpdate on Proposals for 2023 and 2024 Notes
5th Aug 20221:30 pmRNSUpdate on Proposals for 2023 and 2024 Notes
29th Jul 202212:03 pmRNSPJSC Polyus Completes The Buyback Programme
28th Jul 20225:44 pmRNSConsent Solicitation Results and Extension
28th Jul 20225:41 pmRNSConsent Solicitation Results and Extension
20th Jul 20228:06 amRNSNoteholders’ Consent Solicitation Launch
20th Jul 20228:00 amRNSConsent Solicitation Launch Announcement
19th Jul 20225:56 pmRNSEffectiveness of Proposals for 2023 and 2024 Notes
15th Jul 20224:44 pmRNSResults of Consent Solicitation
15th Jul 20224:35 pmRNSResults of the Consent Solicitation
1st Jul 20225:33 pmRNSNoteholders’ consent solicitation extension
1st Jul 20225:23 pmRNSExtension of Consent Solicitation
24th Jun 20223:47 pmRNSNoteholders’ consent solicitation launch
24th Jun 20223:26 pmRNSPolyus Finance Plc announces Consent Solicitation
17th Jun 20222:05 pmRNSAcquisition of the Chulbatkan deposit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.